Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Neutralizing monoclonal antibodies for treatment of COVID-19
Several neutralizing monoclonal antibodies (mAbs) to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical …
coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical …
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
There is considerable interest in the pharmaceutical industry toward development of
antibody-based biotherapeutics because they can selectively bind diverse receptors and …
antibody-based biotherapeutics because they can selectively bind diverse receptors and …
Monoclonal antibody therapies for COVID-19: lessons learned and implications for the development of future products
B Kelley, P De Moor, K Douglas, T Renshaw… - Current Opinion in …, 2022 - Elsevier
Highlights•Multiple companies are authorized to treat COVID-19 patients with monoclonal
antibodies (mAbs).•They were discovered, developed, manufactured, tested, and approved …
antibodies (mAbs).•They were discovered, developed, manufactured, tested, and approved …
Stop** epidemics when and where they occur
Democratic Republic of the Congo, and Central African Republic for many years, it was only
when the virus spread globally during 2022 that high-income countries focused on the …
when the virus spread globally during 2022 that high-income countries focused on the …
Continuous multi‐column capture of monoclonal antibodies with convective diffusive membrane adsorbers
F Schmitz, E Knöchelmann, T Kruse… - Biotechnology and …, 2024 - Wiley Online Library
Downstream processing is the bottleneck in the continuous manufacturing of monoclonal
antibodies (mAbs). To overcome throughput limitations, two different continuous processes …
antibodies (mAbs). To overcome throughput limitations, two different continuous processes …
SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
T Qiu, L Zhang, Z Chen, Y Wang, T Mao… - Nucleic Acids …, 2023 - academic.oup.com
Identifying the exact epitope positions for a monoclonal antibody (mAb) is of critical
importance yet highly challenging to the Ab design of biomedical research. Based on …
importance yet highly challenging to the Ab design of biomedical research. Based on …
[HTML][HTML] High mobility group box 1 (HMGB1): molecular signaling and potential therapeutic strategies
High Mobility Group Box 1 (HMGB1) is a highly conserved non-histone chromatin-
associated protein across species, primarily recognized for its regulatory impact on vital …
associated protein across species, primarily recognized for its regulatory impact on vital …
High-throughput monoclonal antibody discovery from phage libraries: challenging the current preclinical pipeline to keep the pace with the increasing mAb demand
Simple Summary Monoclonal antibodies are increasingly used for a broad range of
diseases. Rising demand must face with time time-consuming and laborious processes to …
diseases. Rising demand must face with time time-consuming and laborious processes to …
Stress factors in protein drug product manufacturing and their impact on product quality
Injectable protein-based medicinal products (drug products, or DPs) must be produced by
using sterile manufacturing processes to ensure product safety. In DP manufacturing the …
using sterile manufacturing processes to ensure product safety. In DP manufacturing the …
Upstream cell culture process characterization and in-process control strategy development at pandemic speed
As of early 2022, the coronavirus disease 2019 (COVID-19) pandemic remains a substantial
global health concern. Different treatments for COVID-19, such as anti-COVID-19 …
global health concern. Different treatments for COVID-19, such as anti-COVID-19 …